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Abstract
Introduction: Although stents have improved the safety and efficacy of percutaneous coronary interventions,
coronary stent thrombosis remains a serious complication.
Case presentation: We present the case of a 64-year-old Caucasian man from Greece, with symptoms and
electrocardiographic findings suggestive of acute inferior myocardial infarction, who complained of chest pain and
rapidly developed cardiogenic shock 48 hours after primary percutaneous coronary intervention.
Conclusion: The most common cause of early bare-metal stent thrombosis is stent malapposition. Intravascular
ultrasound is the preferred method to recognize predictors of coronary events that are not detected by
angiography.
Introduction
Stents have improved the safety and efficacy of percuta-
neous coronary interventions (PCI) by reducing acute or
imminent vessel closure and by reducing restenosis rates
compared with conventional balloon angioplasty [1]. In
addition, coronary vasomotor reactivity has been found
intact after stent implantation and long-term clinical and
angiographic follow-up have attested to the durability of
their action [2]. Nevertheless, coronary stent thrombosis
remains a serious complication of PCI.
Case presentation
A 64-year-old male Caucasian patient was admitted to our
hospital with clinical and electrocardiographical findings
suggesting acute inferior myocardial infarction. Our
patient had a history of hypertension and dyslipidemia but
was not taking any medication at the time of admission.
Laboratory findings were suggestive of acute cardiac ische-
mia. His plasma levels of N-terminal pro-B-type natriure-
tic, troponin I, creatine kinase and creatine kinase MB
isoenzyme were increased. The first transthoracic echocar-
diogram executed at our emergency department showed
hypokinesia of the inferior and posterior left ventricular
wall. Our patient received 600 mg clopidogrel, 325 mg
aspirin and 5000 U of unfractionated heparin and was
then transferred to the catheterization laboratory, while
receiving glycoprotein IIb/IIIa inhibitors (abciximab)
intravenously.
Coronary angiography showed atheromatosis of his left
anterior descending artery and his left circumflex artery
without any evidence of severe stenoses. There was one
severe stenosis (80-90%) at the proximal segment of his
right coronary artery (RCA) and a second, moderate ste-
nosis (40-50%) at its mid segment (Figure 1A).
In view of the angiographic findings, primary PCI was
performed. The intervention started with a predilatation of
the severe lesion with a compliant balloon 2 × 20 mm at
10 Atm, followed by the deployment of a bare-metal chro-
mium-cobalt stent 4 × 16 mm at 14 Atm. The final result
was deemed satisfactory with TIMI III flow, and the fully
expanded stent appropriately sized in length and diameter
(Figure 1B). Our patient was subsequently transferred to
the intensive care unit, where he remained hemodynami-
cally stable for 24 hours while receiving, among other
medications according to the American College of Cardi-
ology/American Heart Association/European Society of
Cardiology guidelines, glycoprotein IIb/IIa inhibitors
(abciximab) intravenously.
Forty-eight hours after admission, our patient com-
plained of chest pain and developed complete heart block
and then asystole, suggestive of acute inferior myocardial
infarction. Our patient went into cardiogenic shock.
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reproduction in any medium, provided the original work is properly cited.Figure 1 Coronary angiography. (A) The angiography showed: a severe stenosis (80-90%) at the proximal segment of the RCA and a second,
moderate stenosis (40-50%) at the mid segment of the aforementioned vessel; (B) the RCA after primary PCI (TIMI III flow); (C) the RCA after
thrombus inspiration with the PRONTO V3 device; (D) results after a balloon dilatation of the stent, which restored a TIMI III flow inside the
vessel: (E) the study of the lesion using the IVUS, which showed the malapposition of the stent; (F) positive results after a balloon dilatation of
the stent with IVUS study.
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intravenously. A temporary pacemaker was placed
through a central venous line. An intra-aortic balloon
pump was also used. A new angiography showed total
occlusion of the proximal segment of his RCA, with
TIMI 0 flow. The intervention proceeded with aspiration
of the thrombus using a PRONTO device (Figure 1C)
and intravascular ultrasound (IVUS) of the culprit lesion
showing malpositioning of the stent (Figure 1E). Finally,
balloon dilatation of the stent and a postdilatation IVUS
study took place (Figure 1F). The procedure successfully
restored TIMI III flow in his RCA (Figure 1D). Our
patient went on to a full and uneventful recovery after
that and was discharge seven days later without any
further complications.
Discussion
Stent thrombosis is defined as an acute thrombotic occlu-
sion in the stented segment of a coronary artery, usually
presenting as ST-segment elevation myocardial infarction
[1], and typically occurs within the first several weeks after
stent placement. Stent thrombosis has traditionally been
categorized as either subacute or early thrombosis, occur-
ring within 30 days, or as late stent thrombosis, occurring
later than 30 days [3]. While very late stent thrombosis,
occurring beyond one year, is been increasingly described
with the use of drug-eluting stents [3], such a thrombosis
is rare with bare-metal stents.
Although early aggressive antiplatelet regimens were
associated with unacceptably high rates of stent thrombo-
sis and bleeding complications, the advent of dual antipla-
telet therapy had salutary effects on both adverse
outcomes.
However, in spite of the recent advancements in
antiplatelet therapies, stentt h r o m b o s i si ss t i l lr e c o g -
nized in 0.5-2% of elective cases, and in up to 6% of
patients with acute coronary syndromes undergoing
PCI [4].
Furthermore, longer stent lengths, large numbers of
implanted stents, stent malapposition, residual dissec-
tions, reduced TIMI flow, gene polymorphisms and resis-
tance to the antiplatelet effects of acetylsalicylic acid and
thienopyridines are reported to increase the risk for stent
thrombosis [1].
Previous studies have reported clinical and angio-
graphic factors predictive of subacute stent thrombosis,
including unstable angina, diabetes, age and long com-
plex lesions [4]. However, these factors alone do not pre-
dict the possibility of periprocedural vessel closure in
individual patients. IVUS provides unique, detailed quali-
tative and quantitative tomographic and transmural ima-
ging of coronary lesions, both pre- and post-intervention.
The factors associated with a higher incidence of sub-
acute stent thrombosis include patient age (> 65 years),
tobacco use and ejection fraction (< 40%). On the other
hand, factors associated with better outcome following
stent thrombosis, are postprocedural TIMI III flow, resi-
dual stenosis < 50% and the use of glycoprotein IIb/IIIa
inhibitors during and after PCI. The use of glycoprotein
IIb/IIIa inhibitors is associated with a lower incidence of
the “no reflow” phenomenon. Moreover, IVUS has the
potential to recognize predictors of coronary events not
detected by angiography.
Conclusion
The most common cause of early bare-metal stent
thrombosis is stent malapposition. This can be attributed
to dissection at the edges of the stent or stent deploy-
ment issues. The latter include incomplete expansion
(occurs when a portion of the stent is inadequately
expanded, compared with the distal and proximal refer-
ence dimensions) and apposition (occurs when part of
the stent is not fully in contact with the vessel wall,
potentially increasing local flow disturbances) [1]. All of
the above mentioned issues can be easily identified by
IVUS which is the preferred method when assessing the
anatomy of a lesion for sizing, position of plaque and
adequacy of stent deployment [5].
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